Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
¿Qué tal es el rendimiento del precio de la acción CBUS?
El precio actual de CBUS es de $2.79, ha aumentado un 0.72% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Cibus Inc?
Cibus Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Cibus Inc?
La capitalización bursátil actual de Cibus Inc es $189.4M
¿Es Cibus Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para Cibus Inc, incluyendo 2 fuerte compra, 6 compra, 2 mantener, 0 venta, y 2 fuerte venta